Previous Article | Next Article ![]()
Infection and Immunity, February 2000, p. 637-643, Vol. 68, No. 2
Groupe de Recherche sur les Maladies
Infectieuses du Porc, Faculté de Médecine
Vétérinaire, Université de Montréal,
Saint-Hyacinthe, Québec, Canada J2S 7C61;
Division of Pediatric Infectious Diseases, University of
California, San Diego, La Jolla, California
92093-06722; Division of Infectious
Diseases, Children's Hospital and Medical Center, Seattle,
Washington 981053; and Division of
Infectious Diseases, Children's Hospital Los Angeles, Los Angeles,
California 900274
Received 19 July 1999/Returned for modification 11 October
1999/Accepted 18 November 1999
Streptococcus suis serotype 2 is a worldwide causative
agent of many forms of swine infection and is also recognized as a zoonotic agent causing human disease, including meningitis. The pathogenesis of S. suis infections is poorly understood.
Bacteria circulate in the bloodstream in the nonimmune host until they come in contact with brain microvascular endothelial cells (BMEC) forming the blood-brain barrier. The bacterial polysaccharide capsule
confers antiphagocytic properties. It is known that group B
streptococci (GBS) invade and damage BMEC, which may be a primary step
in the pathogenesis of neonatal meningitis. Interactions between
S. suis and human endothelial cells were studied to
determine if they differ from those between GBS and endothelial cells.
Invasion assays performed with BMEC and human umbilical vein
endothelial cells demonstrated that unlike GBS, S. suis
serotype 2 could not invade either type of cell. Adherence assays
showed that S. suis adhered only to BMEC, whereas GBS
adhered to both types of cell. These interactions were not affected by
the presence of a capsule, since acapsular mutants from both bacterial
species adhered similarly compared to the wild-type strains. Lactate
dehydrogenase release measurements indicated that some S. suis strains were highly cytotoxic for BMEC, even more than GBS,
whereas others were not toxic at all. Cell damage was related to
suilysin (S. suis hemolysin) production, since only
suilysin-producing strains were cytotoxic and cytotoxicity could be
inhibited by cholesterol and antisuilysin antibodies. It is possible
that hemolysin-positive S. suis strains use adherence and
suilysin-induced BMEC injury, as opposed to direct cellular invasion,
to proceed from the circulation to the central nervous system.
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Streptococcus suis Serotype 2 Interactions with Human Brain Microvascular Endothelial Cells

*
Corresponding author. Mailing address: Groupe de
Recherche sur les Maladies Infectieuses du Porc, Faculté de
Médecine Vétérinaire, Université de
Montréal, C.P. 5000, Saint-Hyacinthe, Québec, Canada J2S
7C6. Phone: (450) 773-8521, ext. 8374. Fax: (450) 778-8108. E-mail:
gottschm{at}medvet.umontreal.ca.
Present address: Unité de Recherche en Vaccinologie, Centre
Hospitalier Universitaire de Québec, Sainte-Foy, Québec,
Canada G1V 4G2.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»